COVID-19vaccine sale: Pharma giants Pfizer-BioNTech and Moderna set to touch the sky by 2023
COVID-19vaccine sale: Pharma giants Pfizer-BioNTech and Moderna set to touch the sky by 2023: 2021 is all set to become quite a year for the pharma companies leading the COVID-19 vaccine race , with significant revenues on the line. The most significant players in the market, pharma giants Pfizer and Moderna are set for the lion's share of 2021 vaccine sales. According to data presented by Finaria.it, BioNTech-Pfizer and Moderna COVID-19 vaccines sales are expected to generate $14.7bn in revenue by 2023. The call for COVID-19 vaccines and treatments has become louder than ever, with countries worldwide facing the full force of the pandemic's second wave. As of January 11, there were over one thousand drugs and vaccines in development targeting the coronavirus disease, revealed the Pharma Intelligence data. More than 60% of them were still in the preclinical phase. However, three candidates were in the pre-registration phase, ...